STAT3 and central nervous system cancer: In high-grade glioma, elevated pSTAT3 levels have been linked to chemo-resistance, and blockade of STAT3 signalling sensitizes glioma cells to chemotherapy, thus providing a rationale for the use of targeted therapies against STAT39.